These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21527061)

  • 1. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.
    Zhou W; Christiani DC
    Chin J Cancer; 2011 May; 30(5):287-92. PubMed ID: 21527061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
    Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
    J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
    Girard N; Sima CS; Jackman DM; Sequist LV; Chen H; Yang JC; Ji H; Waltman B; Rosell R; Taron M; Zakowski MF; Ladanyi M; Riely G; Pao W
    Eur Respir J; 2012 Feb; 39(2):366-72. PubMed ID: 21778168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
    Leidner RS; Fu P; Clifford B; Hamdan A; Jin C; Eisenberg R; Boggon TJ; Skokan M; Franklin WA; Cappuzzo F; Hirsch FR; Varella-Garcia M; Halmos B
    J Clin Oncol; 2009 Nov; 27(33):5620-6. PubMed ID: 19786660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
    Taron M; Ichinose Y; Rosell R; Mok T; Massuti B; Zamora L; Mate JL; Manegold C; Ono M; Queralt C; Jahan T; Sanchez JJ; Sanchez-Ronco M; Hsue V; Jablons D; Sanchez JM; Moran T
    Clin Cancer Res; 2005 Aug; 11(16):5878-85. PubMed ID: 16115929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of rs401681 (C > T) and rs402710 (C > T) polymorphisms in the CLPTM1L region with risk of lung cancer: a systematic review and meta-analysis.
    Wu X; Li W; Chen Y
    Sci Rep; 2024 Sep; 14(1):22603. PubMed ID: 39349641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.
    Ahn MJ; Lee J; Park YH; Ahn JS; Ziogas A; Zell JA; Park K; Ou SH
    J Thorac Oncol; 2010 Aug; 5(8):1185-96. PubMed ID: 20592628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer.
    Li Y; Li Y; Yang T; Wei S; Wang J; Wang M; Wang Y; Zhou Q; Liu H; Chen J
    PLoS One; 2013; 8(1):e52093. PubMed ID: 23341890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
    Shi Y; Au JS; Thongprasert S; Srinivasan S; Tsai CM; Khoa MT; Heeroma K; Itoh Y; Cornelio G; Yang PC
    J Thorac Oncol; 2014 Feb; 9(2):154-62. PubMed ID: 24419411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
    Truong T; Hung RJ; Amos CI; Wu X; Bickeböller H; Rosenberger A; Sauter W; Illig T; Wichmann HE; Risch A; Dienemann H; Kaaks R; Yang P; Jiang R; Wiencke JK; Wrensch M; Hansen H; Kelsey KT; Matsuo K; Tajima K; Schwartz AG; Wenzlaff A; Seow A; Ying C; Staratschek-Jox A; Nürnberg P; Stoelben E; Wolf J; Lazarus P; Muscat JE; Gallagher CJ; Zienolddiny S; Haugen A; van der Heijden HF; Kiemeney LA; Isla D; Mayordomo JI; Rafnar T; Stefansson K; Zhang ZF; Chang SC; Kim JH; Hong YC; Duell EJ; Andrew AS; Lejbkowicz F; Rennert G; Müller H; Brenner H; Le Marchand L; Benhamou S; Bouchardy C; Teare MD; Xue X; McLaughlin J; Liu G; McKay JD; Brennan P; Spitz MR
    J Natl Cancer Inst; 2010 Jul; 102(13):959-71. PubMed ID: 20548021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
    Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population.
    Liam CK; Leow HR; How SH; Pang YK; Chua KT; Lim BK; Lai NL; Kuan YC; Pailoor J; Rajadurai P
    Asian Pac J Cancer Prev; 2014; 15(1):321-6. PubMed ID: 24528049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the risk association of TERT-CLPTM1L rs4975616 (A>G) with lung cancer between Caucasian and Asian populations: A meta-analysis.
    Wu X; Li W; Chen Y
    PLoS One; 2024; 19(9):e0309747. PubMed ID: 39255319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.
    Sun Y; Ren Y; Fang Z; Li C; Fang R; Gao B; Han X; Tian W; Pao W; Chen H; Ji H
    J Clin Oncol; 2010 Oct; 28(30):4616-20. PubMed ID: 20855837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis.
    Lin C; Wang S; Xie W; Chang J; Gan Y
    Cancer Biol Ther; 2015; 16(7):1019-28. PubMed ID: 25975578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.
    Bacchi CE; Ciol H; Queiroga EM; Benine LC; Silva LH; Ojopi EB
    Clinics (Sao Paulo); 2012; 67(5):419-24. PubMed ID: 22666783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsmall cell lung cancer in never smokers.
    Scagliotti GV; Longo M; Novello S
    Curr Opin Oncol; 2009 Mar; 21(2):99-104. PubMed ID: 19532009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang YL; Yuan JQ; Wang KF; Fu XH; Han XR; Threapleton D; Yang ZY; Mao C; Tang JL
    Oncotarget; 2016 Nov; 7(48):78985-78993. PubMed ID: 27738317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer in never smokers: a review.
    Subramanian J; Govindan R
    J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.
    Cote ML; Haddad R; Edwards DJ; Atikukke G; Gadgeel S; Soubani AO; Lonardo F; Bepler G; Schwartz AG; Ethier SP
    J Thorac Oncol; 2011 Mar; 6(3):627-30. PubMed ID: 21317742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.